Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-05 Purchase |
2022-08-08 4:14 pm |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
8,606 | $5.8041 | $49,950 | 198,771 (Direct) |
View |
| 2022-07-19 Sale |
2022-07-20 4:27 pm |
Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer |
3,901 | $6.55 | $25,552 | 109,077 (Direct) |
View |
| 2022-07-19 Sale |
2022-07-20 4:27 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
431 | $6.582 | $2,837 | 53,223 (Direct) |
View |
| 2022-06-17 Sale |
2022-06-21 4:07 pm |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
4,552 | $4.991 | $22,719 | 190,165 (Direct) |
View |
| 2022-06-17 Sale |
2022-06-21 4:06 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
256 | $4.9 | $1,254 | 53,654 (Direct) |
View |
| 2022-06-02 Purchase |
2022-06-03 4:11 pm |
Esperion Therapeutics Inc. | ESPR | CARROLL J MARTIN Director |
5,000 | $5.6359 | $28,180 | 5,000 (Direct) |
View |
| 2022-05-17 Sale |
2022-05-18 4:30 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
196 | $5.981 | $1,172 | 53,910 (Direct) |
View |
| 2022-03-17 Sale |
2022-03-18 4:29 pm |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
571 | $4.58 | $2,615 | 194,717 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-07 Option Award |
2022-06-09 4:48 pm |
N/A 2032-06-07 |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
91,000 | $0 | 91,000 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 4:47 pm |
N/A 2032-06-07 |
Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel |
52,000 | $0 | 52,000 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 4:46 pm |
N/A 2032-06-07 |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
52,000 | $0 | 52,000 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 4:46 pm |
N/A 2032-06-07 |
Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer |
52,000 | $0 | 52,000 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-01 4:24 pm |
N/A 2032-06-01 |
Esperion Therapeutics Inc. | ESPR | CARROLL J MARTIN Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 4:20 pm |
N/A 2032-05-26 |
Esperion Therapeutics Inc. | ESPR | Berkowitz Jeffrey Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 4:19 pm |
N/A 2032-05-26 |
Esperion Therapeutics Inc. | ESPR | Fischer Seth H. Z. Director |
11,561 | $0 | 11,561 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 4:18 pm |
N/A 2032-05-26 |
Esperion Therapeutics Inc. | ESPR | VITULLO NICOLE Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 4:17 pm |
N/A 2032-05-26 |
Esperion Therapeutics Inc. | ESPR | Woody Tracy M Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 4:15 pm |
N/A 2032-05-26 |
Esperion Therapeutics Inc. | ESPR | Shepard Jay Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 4:14 pm |
N/A 2032-05-26 |
Esperion Therapeutics Inc. | ESPR | GOTTO ANTONIO M JR MD D PHIL Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 4:13 pm |
N/A 2032-05-26 |
Esperion Therapeutics Inc. | ESPR | ROCAMBOLI STEPHEN Director |
41,589 | $0 | 41,589 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 4:12 pm |
N/A 2032-05-26 |
Esperion Therapeutics Inc. | ESPR | Fuhrman Alan Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-03-14 Option Award |
2022-03-16 5:11 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
13,000 | $0 | 111,106 (Direct) |
View |
| 2022-03-14 Option Award |
2022-03-16 5:10 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer |
28,000 | $0 | 231,978 (Direct) |
View |
| 2022-03-14 Option Award |
2022-03-16 5:09 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Bartram Richard Chief Financial Officer |
37,000 | $0 | 241,751 (Direct) |
View |
| 2022-03-14 Option Award |
2022-03-16 5:08 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
116,000 | $0 | 687,288 (Direct) |
View |
Ownership |
2022-03-09 4:53 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
0 | $0 | 41,106 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-28 5:07 pm |
N/A 2032-01-27 |
Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel |
171,250 | $0 | 171,250 (Direct) |
View |
| 2021-10-29 Option Award |
2021-11-01 4:48 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
26,700 | $0 | 114,550 (Direct) |
View |
| 2021-10-29 Option Award |
2021-11-01 4:48 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Bartram Richard Chief Financial Officer |
18,700 | $0 | 70,352 (Direct) |
View |
| 2021-10-29 Option Award |
2021-11-01 4:48 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer |
22,450 | $0 | 116,828 (Direct) |
View |
| 2021-06-28 Option Award |
2021-07-08 07:30 am |
N/A 2031-06-28 |
Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer |
151,220 | $0 | 151,220 (Direct) |
View |
| 2021-06-28 Option Award |
2021-06-30 4:27 pm |
N/A 2031-06-28 |
Esperion Therapeutics Inc. | ESPR | Bartram Richard Chief Financial Officer |
63,900 | $0 | 63,900 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 4:19 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Berkowitz Jeffrey Director |
12,376 | $0 | 23,449 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 4:19 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Fuhrman Alan Director |
12,376 | $0 | 25,254 (Direct) |
View |